4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-25-006331
EVP & Group Pres, Cardiology sold 50,000 shares at $106.97 ($5,348,315)
- EVP & Group Pres, Cardiology acquired 50,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | 2025-07-01 | Option exercise 10b5-1 | +50,000 | $26.15 | $1,307,500 | 228,342 | D |
| Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | 2025-07-01 | Sale 10b5-1 | −50,000 | $106.97 | $5,348,315 | 178,342 | D |
| Derivatives | |||||||
| Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | 2025-07-01 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,000 | 200,000 | D | ||
| Open-market sales · 50,000 sh · avg $106.97 · $5,348,315 | |||||||
Loading xslF345X05/doc4.xml…